Krishna Banaudha Associate Professor, The George Washington UniversityDr. Krishna K. Banaudha obtained a Ph. D. in Pharmacology, postgraduate Diploma in Public Administration, Law degree from University of Lucknow, UP India Fellow of Medical Research Fellowship USA. Dr. Banaudha used his leadership skills in promoting health care awareness programs in the field of Cancer, infectious diseases like HIV & HCV for the community as well as in his scientific career where he made several contributions in bringing about three new therapeutic drugs to the market. He is Personal Ambassador and Director of Webcasting education of St. Laurent Institute. He organizes workshops on Science and Technology at Tirupati University and a member of International advisory Committee of “Network of IndianUniversities on Cultural and Biological Diversity”. Dr. Krishna is a Scientific Advisor of Guardian Health System of the India Program on Tuberculosis Diagnostics. CEO Export Unit USA, Prosix provides third Party Software Implementation Support as well as conducts training programs for management, users, and programmers on MIS, System Software,Development Tools and Application Software.
Dr. Banaudha is founder member of the Lucknow Researcher Alumni Association have more than thousand members, which advocates the awareness of scientific development of the medicinal research. Dr. Banaudha takes active interest in the Indian Diaspora community affairs in the Washington, DC Metropolitan Region. He is on the Advisory Committees of two leading community associations. Under his leadership Indian American community has strengthened the friendly relationship of the two largest democracies in the world. Dr. Banaudha has also working diligently in the advancement of science and Biotechnology in the two largest scientific communities in the world to strive for a common goal, to end human disease and suffering. | | | Jyoti Chattopadhyaya Professor, Uppsala UniversityProfessor Jyoti Chattopadhyaya is a Chair of Bioorganic Chemistry since 1980, and is also the Chair of the Chemical Biology Program at the University of Uppsala, Sweden. His multidisciplinary research in Chemistry-Biology interface has so far resulted, in over 420 publications in various peer-reviewed Journals (see http://www.boc.uu.se). He is a member of Editorial Board of over 18 International Journals. His research focuses on (a) design of gene (RNA)-directed therapeutics. (b) Physical and structural chemistry of DNA and RNA foldings by high-field multinuclear NMR spectroscopy. (c) design and synthesis of drug against resistant bacteria. Average Citations per item: 38.46; H-index: 64. | | |
|